Pharmafile Logo

Peter Impey

UK flag

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities

- PMLiVE

Pharma’s shrinking waterhole

A natural metaphor makes us think about our strategy

- PMLiVE

UDG buys Galliard and Nyxeon

Will add UK comms firms to Ashfield Healthcare Communications division

Baxter reshuffles financial heads

Names CFOs for biotech spin-off and 'new' Baxter

- PMLiVE

Illumina to provide sequencing for UK gene project

Genomics England wants company to sequence genomes of 100,000 NHS patients

- PMLiVE

EU hits Servier and generic firms with €428m ‘pay-for-delay’ fine

Follows deals to delay competition for blood pressure drug Coversyl/Aceon

Novartis building

Novartis’ secukinumab tops Enbrel in psoriasis

Data reinforces secukinumab's position among new generation of biologic

France flag

Pharma criticises France’s backing for off-label Avastin use

EFPIA weighs in on proposal to move wet AMD patients to the drug as a cheaper alternative

- PMLiVE

Mars appoints chief health officer

Debra Sandler assumes newly-created role

- PMLiVE

Drug apps should be reviewed by pharmacists

EAHP advises that any app linked to the use of medicines must have regulatory oversight to ensure safety

- PMLiVE

NICE backs Lundbeck’s alcohol dependence drug Selincro

Alcoholics in England to have access to once-daily drug

- PMLiVE

CHC hires first full-time account director

Sarah Newman joins comms agency from Galliard

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links